Management and treatment of hepatitis C virus in patients with HIV and hepatitis C virus coinfection:: A practical guide for health care professionals

被引：9

作者：

Cote, Pierre ^{[1
,2
]}

Baril, Jean-Guy ^{[1
,2
]}

Hebert, Marie-Nicole

Klein, Marina

Lalonde, Richard

Poliquin, Marc ^{[2
]}

Rouleau, Danielle ^{[2
]}

Therrien, Rachel ^{[2
]}

Vezina, Sylvie ^{[2
]}

Willems, Bernard ^{[2
]}

Dion, Harold ^{[3
]}

Junod, Patrice ^{[2
]}

Lapointe, Normand ^{[4
]}

Levesque, Dominic ^{[5
]}

Pinault, Lyse ^{[6
]}

Tremblay, Cecile ^{[2
]}

Trottier, Benoit ^{[2
]}

Trottier, Sylvie ^{[7
]}

Tsoukas, Chris

Piche, Alain ^{[8
]}

机构：

[1] Clin Med Quartier Latin, Montreal, PQ H2L 5B1, Canada

[2] Ctr Hosp Univ Montreal, Montreal, PQ, Canada

[3] Coll Quebecois Med Famille, Quebec Coll Family Phys, Quebec City, PQ, Canada

[4] Hop St Justine, Ctr Maternel & Infantile Sida, Montreal, PQ, Canada

[5] Comite Personnes Atteintes VIH Quebec CPAVIH, Montreal, PQ, Canada

[6] Coalit Organismes Communautaires Quebecois Lutte, COCQ Sida, Montreal, PQ, Canada

[7] Ctr Hosp Univ Quebec, Ste Foy, PQ, Canada

[8] Ctr Hosp Univ Sherbrooke, Sherbrooke, PQ, Canada

来源：

CANADIAN JOURNAL OF INFECTIOUS DISEASES & MEDICAL MICROBIOLOGY | 2007年 / 18卷 / 05期

关键词：

antiretrovirals; coinfection; hepatitis C virus; HIV; practical guide; HUMAN-IMMUNODEFICIENCY-VIRUS; ALPHA-2A PLUS RIBAVIRIN; INFECTED PATIENTS; NATURAL-HISTORY; ANTIRETROVIRAL THERAPY; RISK-FACTORS; DOSE PHARMACOKINETICS; SEVERE HEPATOTOXICITY; PROTEASE INHIBITOR; LACTIC-ACIDOSIS;

D O I：

10.1155/2007/631054

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

Concomitant HIV and hepatitis C virus (HCV) is a common yet complex coinfection. The present document is a practical guide for treating HCV infection in people coinfected with HIV. Effective anti-retroviral therapies have prolonged survival rates for HIV-infected people over the past decade, which have made latent complications of HCV major causes of morbidity and mortality in these patients. Advances in the treatment of HCV (eg, combined pegylated interferon and ribavirin) offer the possibility of eradicating HCV infection in coinfected persons. The treatment of HCV must be considered in all cases. Intensive management of the adverse effects of HCV treatment is one of the factors for the success of these therapies. HCV eradication is predicted to decrease the mortality associated with coinfection and reduce the toxicity of HIV treatment.

引用

页码：293 / 303

页数：11

共 90 条

[61]

PARENT R, 2004, EPIDEMIOLOGIE VIH VH, P48

[62]

PIROTH L, 2007, CLASSIFICATION HEPAT

[63] Steatosis: Co-factor in other liver diseases [J].

Powell, EE ;

Jonsson, JR ;

Clouston, AD .

HEPATOLOGY, 2005, 42 (01) :5-13

[64] A comparison of fibrosis progression in chronic liver diseases [J].

Poynard, T ;

Mathurin, P ;

Lai, CL ;

Guyader, D ;

Poupon, R ;

Tainturier, MH ;

Myers, RP ;

Muntenau, M ;

Ratziu, V ;

Manns, M ;

Vogel, A ;

Capron, F ;

Chedid, A ;

Bedossa, P .

JOURNAL OF HEPATOLOGY, 2003, 38 (03) :257-265

[65] Hepatitis C virus (HCV) and human immunodeficiency virus type 1 (HIV-1) infections in alcoholics [J].

Prakash, O ;

Mason, A ;

Luftig, RB ;

Bautista, AP .

FRONTIERS IN BIOSCIENCE-LANDMARK, 2002, 7 :E286-E300

[66]

Public Health Agency of Canada Surveillance and Risk Assessment Division Centre for Infectious Disease Prevention and Control, 2007, HIV AIDS EP UPD

[67] TRANSECTION OF ESOPHAGUS FOR BLEEDING ESOPHAGEAL VARICES [J].

PUGH, RNH ;

MURRAYLY.IM ;

DAWSON, JL ;

PIETRONI, MC ;

WILLIAMS, R .

BRITISH JOURNAL OF SURGERY, 1973, 60 (08) :646-649

[68] Severe hepatotoxicity during combination antiretroviral treatment: Incidence, liver histology, and outcome [J].

Puoti, M ;

Torti, C ;

Ripamonti, D ;

Castelli, F ;

Zaltron, S ;

Zanini, B ;

Spinetti, A ;

Putzolu, V ;

Casari, S ;

Tomasoni, L ;

Quiros-Roldan, E ;

Favret, T ;

Berchich, L ;

Grigolato, T ;

Callea, F ;

Carosi, G .

JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2003, 32 (03) :259-267

[69] Unsafe sex and increased incidence of hepatitis C virus infection among HIV-infected men who have sex with men: The swiss HIV cohort study [J].

Rauch, A ;

Rickenbach, M ;

Weber, R ;

Hirschel, B ;

Tarr, PE ;

Bucher, HC ;

Vernazza, P ;

Bernasconi, E ;

Zinkernagel, AS ;

Evison, J ;

Furrer, H .

CLINICAL INFECTIOUS DISEASES, 2005, 41 (03) :395-402

[70] Clinical pharmacokinetics of Nelfinavir and its metabolite M8 in human immunodeficiency virus (HIV)-positive and HIV-hepatitis C virus-coinfected subjects [J].

Regazzi, M ;

Maserati, R ;

Villani, P ;

Cusato, M ;

Zucchi, P ;

Briganti, E ;

Roda, R ;

Sacchelli, L ;

Gatti, F ;

Delle Foglie, P ;

Nardini, G ;

Fabris, P ;

Mori, F ;

Castelli, P ;

Testa, L .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2005, 49 (02) :643-649

← 1 2 3 4 5 6 7 8 9 →